drugset
Drugs / Influenza vaccine, split inactivated
last change Mar 2016 re-read 3 minutes ago

Influenza vaccine, split inactivated

also known as TIV

Vaccine

Developed for
influenza
Investigated by
Comac Medical · Department of Health and Human Services · Institute of Virology, Vaccines and Sera, Torlak · PATH · World Health Organization

Trials 1

today NCT02585700 · Ph 1
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02585700 Nov 2015 → Mar 2016 influenza Institute of Virology, Vaccines and Sera, Torlak Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Influenza vaccine, split inactivated ClinicalTrials.gov intervention name — accepted as the source's own label NCT02585700 ↗
Known as TIV “Seasonal trivalent inactivated influenza vaccine (TIV)” NCT02585700 ↗
Modality Vaccine “Seasonal trivalent inactivated influenza vaccine (TIV)” NCT02585700 ↗